[1] Papazian L, Klompas M, Luyt CE.Ventilator-associated pneumonia in adults: a narrative review[J]. Intensive Care Med, 2020, 46(5): 888-906. [2] Tomasz G, Ewa W, Jolanta M. Biomarkers of iron metabolism in chronic kidney disease[J]. Int Urol Nephrol, 2020 Oct 6 [Online ahead of print]. [3] 邱泽亮, 沈侃, 舒铭, 等. 血清铁调素Hepcidin在成人重症患者脓毒症临床诊断中的价值[J]. 中华危重病急救医学, 2018, 30(7): 652-657. [4] 中华医学会重症医学分会. 呼吸机相关性肺炎诊断、预防和治疗指南(2013)[J]. 中华内科杂志, 2013, 52(6): 524-543. [5] Modi AR, Kovacs CS.Hospital-acquired and ventilator-associated pneumonia: Diagnosis, management, and prevention[J]. Cleve Clin J Med, 2020, 87(10): 633-639. [6] Jansma G, de Lange F, Kingma WP, et al. 'Sepsis-related anemia' is absent at hospital presentation; a retrospective cohort analysis[J]. BMC Anesthesiol, 2015,15: 55-61. [7] 李福兴, 谢可心, 张玉琳, 等. 铁调素在脓毒症相关性贫血中的研究进展[J]. 解放军医学杂志, 2020, 45(12): 1299-1303. [8] Martins AC, Almeida JI, Lima IS, et al.Iron metabolism and the inflammatory response[J]. IUBMB Life, 2017, 69(6): 442-450. [9] Alessandri F, Pugliese F, Angeletti S, et al.Procalcitonin in the assessment of ventilator associated pneumonia: a systematic review[J]. Adv Exp Med Biol, 2020 [Online ahead of print]. [10] Zhou XY, Ben SQ, Chen HL, et al.A comparison of APACHE Ⅱ and CPIS scores for the prediction of 30-day mortality in patients with ventilator-associated pneumonia[J]. Int J Infect Dis, 2015, 30: 144-147. [11] Liu D, Su LX, Guan W, et al.Prognostic value of procalcitonin in pneumonia: a systematic review and meta-analysis[J]. Respirology, 2016, 21(2): 280-288. [12] Khorramian E, Fung E, Chua K, et al.In a mouse model of sepsis, hepcidin ablation ameliorates anemia more effectively than iron and erythropoietin treatment[J]. Shock, 2017, 48(4): 490-497. |